Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 89.40
-0.80 (-0.89%)
Mar 2, 2026, 5:24 PM CET
Devyser Diagnostics AB Revenue
In the year 2025, Devyser Diagnostics AB had annual revenue of 250.50M SEK with 15.49% growth. Devyser Diagnostics AB had revenue of 72.00M in the quarter ending December 31, 2025, with 12.15% growth.
Revenue
250.50M
Revenue Growth
+15.49%
P/S Ratio
5.94
Revenue / Employee
2.16M
Employees
116
Market Cap
1.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 250.50M | 33.60M | 15.49% |
| Dec 31, 2024 | 216.90M | 47.60M | 28.12% |
| Dec 31, 2023 | 169.30M | 42.70M | 33.73% |
| Dec 31, 2022 | 126.60M | 33.12M | 35.43% |
| Dec 31, 2021 | 93.48M | 27.79M | 42.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| BICO Group AB | 1.50B |
| Surgical Science Sweden AB | 992.34M |
| Stille AB | 567.63M |
| EQL Pharma AB | 425.75M |